Despite growing precision in understanding the biology of breast cancer, progress in extending survival of people with metastatic disease remains frustratingly slow. Median survival is only about three years, having edged up only slightly in [more]
For many patients seeking access to treatments unavailable in their home country, the Cross-border Healthcare Directive turned out to be a bit of a disappointment. But a closer look shows it may help raise standards [more]
The European Commission is predicting that by 2020 Europe will need an additional one million clinical professionals to care for its ageing population. With many of our cancer systems already working at full capacity, this [more]
Generics markets are gearing up for the expiry of patents on some of the first targeted cancer drugs. Its good news for greater access, but patients want reassurance that switching to generics wont put them [more]
We wont improve cancer care until we know more about how well we are doing and how alternative approaches compare. It sounds obvious, but its not happening, says the real David Cameron Something in the [more]
Urology surgeon Nicola Nicolai proposes key criteria for sustainable services that provide each patient with access to the level of specialist services that they need. Debates about the benefits and drawbacks of centralising the planning [more]